ANAHEIM, Calif., /PRNewswire-iReach/ -- Headquartered in Anaheim, California, WholeHealth Products is a diversified company comprised of several specialized partners focused on leveraging the power ...
PARIS — A single cardiac troponin measurement by high-sensitivity cardiac troponin I (hs-cTnI) assay can safely and effectively rule out myocardial infarction (MI) at presentation, results from more ...
Please provide your email address to receive an email when new articles are posted on . Abbott announced that a high-sensitivity troponin I blood test used to detect MI has received FDA clearance. The ...
Many patients presenting to the emergency department with a suspected acute MI could be sent home on the basis of just one measurement of cardiac troponin I using a high-sensitivity assay, suggest ...
ABBOTT PARK, Ill., Sept. 25, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its ARCHITECT STAT High Sensitivity Troponin-I blood test has received clearance from the U.S. Food and Drug ...
Please provide your email address to receive an email when new articles are posted on . Using a novel saliva-based rapid cardiac troponin I test to diagnose MI was feasible, according to the results ...
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...
The US Food and Drug Administration (FDA) has approved the Architect Stat (Abbott Laboratories) high-sensitivity troponin-I assay, which can detect myocardial infarction (MI) faster and more ...
Abbott Laboratories ABT recently attained the FDA approval for its ARCHITECT STAT High Sensitivity Troponin-I blood test. This is one of the most meticulously-researched troponin diagnostic tests, ...
PATHFAST hs-cTnI-II becomes first and only hs-cTn test cleared for point-of-care use in the United States, delivering results up to three times faster than core lab testing CORTLANDT MANOR, N.Y., ...
A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency. Blood sample tests for ...
Chest pain and suspected myocardial infarction were the cause of about 5% of all emergency hospital admissions in 2017 to 2018. However, myocardial infarction will have occurred in only about 20% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results